On September 23, 2020 DLA Piper represented MEDNAX, Inc., the national health solutions partner and leading provider of maternal-fetal, newborn and pediatric subspecialty care, in the sale of MEDNAX Radiology Solutions to Radiology Partners, a leading physician-led and physician-owned radiology practice, for US$885 million (Press release, DLA Piper (US), SEP 23, 2020, View Source [SID1234565198]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Founded in 2015, MEDNAX Radiology Solutions is an integrated provider of seamless on-the-ground and in-the-cloud radiology services, delivering scale and value to hospitals, clinics, imaging centers and referring physicians through a combination of highly innovative physician groups and vRad, the nation’s leading teleradiology organization.
"We were pleased to advise our long-time client MEDNAX in its sale of MEDNAX Radiology Solutions. Our extensive experience advising healthcare clients on strategic M&A initiatives and our long-term relationship with MEDNAX were important assets in our handling of this transaction," said Joshua Samek, the DLA Piper partner who led the firm’s deal team. "We appreciate the opportunity to work with the entire MEDNAX team as they support the company’s mission of taking great care of the patient, every day and in every way."
In addition to Samek (Miami), the DLA Piper team representing MEDNAX included partners Russell Sass (Miami), Brian Gordon, Jamie Konn (both of Atlanta), Rita Patel, Jennifer Kashatus (both of Washington, DC), Jordan Bailowitz (Baltimore), Jamie Knox, Paolo Morante (both of New York), Randy Peak (Dallas) and Nathaniel McKitterick (Silicon Valley); of counsel Sanjay Beri (Northern Virginia) and Nia Brown (Washington, DC); senior attorney Michelle Winbush (Baltimore); associates Julia Zaft, Summer Galitz, Adriana Valldejuly (all of Miami), James Rusert, Alvin Johnson, Julie Franki (all of Atlanta), Mary Claire Blythe (Baltimore), Michael Goldstein (Short Hills), Jessica Wright (New York) and Tiffany Nguyen (Northern Virginia); and attorneys Renae Flowers (Austin) and Virginia Lewey (Chicago).
The transaction is expected to close in the fourth quarter of 2020 subject to customary closing conditions, including regulatory review.
With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex cross-border transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for ten consecutive years, according to Mergermarket.
The firm’s global Healthcare sector consists of a multidisciplinary legal team with niche experience in health-related business and legal issues. The team regularly works with corporations and financial institutions, private investors, private equity groups, venture capital funds, institutional investors and portfolio companies in all types of healthcare transactions.